Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Pozycja w akcjach #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Cena akcji
$0.21291741
Ostatnia synchronizacja: 2025-04-18
Kapitalizacja rynkowa
$12.07M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
KR
Handel PCL, Inc. (241820)

Kategoria

Zyski dla PCL, Inc. (241820)
Zyski w Sep 2025 TTM: $-33.90M
Według najnowszych raportów finansowych PCL, Inc., obecny zysk firmy wynosi $-33.90M. W roku 2023 firma osiągnęła zysk w wysokości $-15.73M, spadek w porównaniu do zysku z roku 2022, który wynosił $-3.18M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy PCL, Inc. od 2015 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-33.90M -5.68%
2024 $-35.94M 128.48%
2023 $-15.73M 394.91%
2022 $-3.18M -88.07%
2021 $-26.64M -248.25%
2020 $17.97M -360.49%
2019 $-6.90M 33.10%
2018 $-5.18M 42.76%
2017 $-3.63M 87.03%
2016 $-1.94M 22.38%
2015 $-1.59M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$7.51B -22,254.56%
US
$5.15B -15,284.62%
US
$5.56B -16,508.71%
IE
$3.86B -11,488.46%
US
$1.42B -4,281.37%
US